Mesoblast Limited vs Teucrium Wheat Fund — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Teucrium Wheat Fund trades at $25.21. The key difference: Teucrium Wheat Fund is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| MESO | WEAT | |
|---|---|---|
Market Cap | $2.17B | — |
Sector | Technology | Commodities - Metals/Agriculture |
52-Week High | $20.96 | $25.49 |
52-Week Low | $12.88 | $19.88 |
Enterprise Value | $2.17B | — |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →